Name

PHC Holdings

Legal name

PHC Holdings Corporation

Website

https://www.phchd.com/jp

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Medical Devices and Healthcare Technology

NAICS

Software Publishers (513210), Management of Companies and Enterprises (551)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Medical device manufacturing
• Diagnostic instruments
• Diabetes management
• Anatomical pathology
• Life sciences equipment

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices12 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Life Sciences and Biomedical Equipment Sales: Sale of research and medical support equipment including ultra-low temperature freezers, CO2 incubators, pharmaceutical refrigerators, and cell culture systems. Products sold directly and through distribution channels globally.
2. Diabetes Management Products: Blood glucose monitoring systems (BGM) and digital diabetes management solutions sold through Ascensia Diabetes Care subsidiary in over 90 countries, serving approximately 10 million users worldwide
3. Diagnostic Reagents and Instruments: In vitro diagnostic reagents measuring blood components including coagulation and fibrinolysis, immunochromatography reagents for influenza and COVID-19, and compact immunoassay analyzers like PATHFAST
4. Healthcare IT Solutions: Electronic medical record systems (Medicom), electronic medication history systems (PharnesX), and health guidance systems provided through Wemex subsidiary for clinics, hospitals, and pharmacies in Japan
5. Clinical Testing Services: Laboratory analysis services in clinical testing, cancer diagnostics, genetic testing, and sports anti-doping testing provided through LSI Medience

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

PHC Holdings Corporation is a diversified healthcare technology group that develops, manufactures, and sells medical devices and equipment across three business domains: Diabetes Management (blood glucose monitoring systems and digital diabetes solutions via Ascensia), Life Sciences and Diagnostics (ultra-low temperature freezers, CO2 incubators, pharmaceutical refrigerators, cell therapy products, and in vitro diagnostic reagents via PHC Corporation, LSI Medience, and Epredia), and Healthcare Solutions (electronic medical records, medication history systems, and contract research services via Wemex and Mediford). Its products serve patients, healthcare professionals, and researchers in more than 125 countries.

Product overview

PHC Holdings Corporation operates as a diversified healthcare technology group organized across three business domains: Diabetes Management, Life Sciences and Diagnostics, and Healthcare Solutions. The product portfolio includes the Ascensia brand of blood glucose monitoring systems and digital diabetes management apps; PHCbi-branded life sciences equipment including ultra-low temperature freezers (TwinGuard, VIP ECO, VIP Series), CO2 incubators with H2O2 decontamination, pharmaceutical refrigerators, and cell therapy products (LiCellMo metabolic analyzer, LiCellGrow expansion system under development); LSI Medience clinical testing and diagnostic reagents including the PATHFAST immunoassay analyzer; Wemex's Medicom electronic medical record systems, Medicom-HRf Hybrid Cloud, and PharnesX medication history systems for healthcare facilities; Epredia anatomical pathology and digital pathology solutions including whole slide imaging scanners; and Mediford contract research services. The company serves patients, healthcare professionals, and researchers in over 125 countries through its group subsidiaries.

Differentiator

Problem solved

Functional benefit

Brands

• Cell-IQ: CO2 Incubator series featuring active hybrid humidification technology for life science research
• TwinGuard
• LiCellGrow
• LiCellMo
• E1000 Dx
• CONTOUR
• PATHFAST
• Medicom

Products and services

• PHCbi Ultra-Low Temperature Freezers (VIP and TwinGuard series) CFC-free ultra-low temperature freezers with proprietary TwinGuard dual cooling system and VIP PLUS vacuum insulation for sample and specimen storage. ENERGY STAR certified with industry-leading energy-saving performance; supports hospital labs, biorepositories, and pharmaceutical storage.
• PHCbi CO2 Incubators (Cell-IQ series) CO2 incubators with active hybrid humidification technology, antimicrobial copper-alloy stainless steel interiors, UV-LED sterilization, and H2O2 decontamination for cell culture applications in research and biopharmaceutical laboratories.
• PHCbi Pharmaceutical Refrigerators (MPR Series) Pharmaceutical refrigerators for vaccine and critical medication storage, built in compliance with CDC pharmacy guidelines; models range from 158 to 1364 liters with natural refrigerant options.
• LiCellMo Live Cell Metabolic Analyzer Live cell metabolic analyzer measuring cellular metabolic changes continuously in real time using proprietary high-precision in-line sensors while maintaining sterility. Supports cancer research, stem cell therapies, and process development.
• LiCellGrow Cell Expansion System

Quantifiable outcome

• Humidity recovery speeds approximately twice as fast as previous models
• +3 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered major, minor and core.

• Senseonics HoldingsmajorStrategic or Co-development Partner · 1 January 2026Partnership for Eversense Continuous Glucose Monitoring (CGM) products. PHC transferred commercial activities for the CGM business to Senseonics, with Ascensia previously distributing the products. The transition was completed in January 2026, with Senseonics assuming full commercial control of Eversense CGM platforms.
• BayermajorTechnology or Integration · 1 January 2025CGM business partnership involving transfer of commercial activities to Senseonics and Bayer. The Eversense 365 CGM system was previously distributed through this partnership arrangement.
• Centre for Commercialization of Regenerative Medicine (CCRM)minorStrategic or Co-development PartnerPHC Group collaborated with CCRM to host an online roundtable discussion on the potential, challenges, and future outlook of CAR-T therapy in cancer treatment, exploring cell and gene therapy applications.
• JCR PharmaceuticalscoreStrategic or Co-development PartnerOngoing collaboration for medication management solutions including GROWJECTOR automated injection devices and Melon Nikki medication management app for pediatric patients undergoing growth hormone therapy.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Thermo Fisher Scientific: Global life sciences tools leader from which PHC acquired the Anatomical Pathology business (Epredia) in 2019. Overlaps in laboratory equipment, diagnostics, and pathology — the most direct comparable given the shared history and product categories.
• Abbott Laboratories: Diversified medical device and diagnostics company with a dominant diabetes care franchise (FreeStyle Libre CGM, BGM). Comparable to PHC's Ascensia diabetes management business and overall diversified medical device portfolio.
• Roche Diabetes Care: Major diabetes management competitor (Accu-Chek) with extensive BGM/CGM offerings and integrated diagnostic solutions. Closely comparable to PHC's Ascensia division in target market and product overlap.
• Danaher Corporation: Life sciences and diagnostics conglomerate operating Beckman Coulter, Cepheid, Leica Biosystems (pathology), and more. Comparable in diversified life sciences tools, diagnostics, and pathology exposure.
• Becton Dickinson (BD): Major medical device and life sciences research tools manufacturer. Comparable in clinical laboratory equipment, diagnostic systems, and biomedical research instruments — overlapping with PHC Corporation's equipment portfolio.
• Agilent Technologies: Life sciences tools and diagnostics company providing analytical instruments and lab equipment. Comparable to PHC's biomedical division products (incubators, freezers) serving research and clinical laboratories.

Direct peers

• Eppendorf AG: German life sciences equipment manufacturer specializing in CO2 incubators, ULT freezers, bioreactors, and cell handling consumables. Direct competitor to PHCbi in the same product categories and customer base of research/biotech labs.
• Dexcom: Continuous glucose monitoring market leader and beneficiary of PHC's CGM exit to Senseonics/Bayer. Comparable as a competitor in diabetes monitoring that PHC ceded ground to in the CGM category.
• Sartorius AG: German bioprocessing and laboratory equipment manufacturer providing bioreactors and cell culture tools. Comparable to PHC's LiCellGrow/LiCellMo cell expansion and metabolic monitoring systems targeting CGT manufacturing.

Regional players

• Hamamatsu Photonics: Japanese technology company with diagnostics and digital pathology imaging solutions. Regional comparable to Epredia's whole-slide imaging scanners and PHC's broader biomedical device portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCW4dStNHrK-E-qaZEzpoCWw
• Facebookfacebook.com/PHCHoldingsGlobal
• LinkedInlinkedin.com/company/phc-holdings

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries9 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PHC Holdings